The Earlier the Better: Probing Malignancies in Newborns
(L-R) Prof.Wolfgang Holzgreve, Prof. Marek Glazerman, Prof. Israel Meisner
Building on their established international partnership, GE Healthcare and Rabin Medical Center are developing innovative products and working on creative medical solutions to facilitate the early diagnosis of medical problems in pregnant women and their fetuses. An international data registry on fetal tumors is already in progress, which will assist in treating malignant conditions in both fetuses and newborns. Prof. Israel Meisner, head of RMC's Obstetric Ultrasound Unit, said tumors such as Neuroblastoma can be fully cured if discovered early in a fetus, and he believes this registry is important.
The data registry project was inaugurated during a conference at Rabin Medical Center on Women's Healthcare organized by GE Healthcare Israel, headed by Tony Bachar, and by the Rabin Medical Center's Women's Hospital, headed by Prof. Marek Glazerman. Among the honored guests present was Prof. Wolfgang Holzgreve, head of obstetrics and gynecology at the renowned University of Basel in Switzerland.
Related Articles
Early Menopause - Serious Issue for Breast Cancer Patients
In Israel, this year alone, about 1,000 women under the age of 50 will discover they have breast cancer. If this is not devastating enough, many of these young women, still of childbearing age, will go into early menopause as a result of life saving chemotherapy treatments.
New Hope for the Blind
Rabin Medical Center has performed the first artificial cornea transplant in Israel, bringing new hope to patients who are blind.
Male fetuses are more trouble
Judy Siegel-Itzkovich, THE JERUSALEM POST
It isn't an "old wives' tale" that carrying a male fetus is more "troublesome" than carrying a female fetus, according to research encompassing over 66,000 women who gave birth at the Rabin Medical Center (RMC) in Petah Tikva between 1995 and 2006.